Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B C Langton

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1987
Structural considerations of T-cell cognizance of antigenE Benjamini, B C Langton, C E Mackewicz
Molecular Carcinogenesis|February 1, 1996
Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alphaS P Ethier, B C Langton, C A Dilts
Developments in Biological Standardization|January 1, 1986
Cell activation and immunogenicityE Benjamini, A M Wan, B C Langton, et al.
Cellular Immunology|March 1, 1991
Structural aspects of a protein epitope and their role in the major histocompatibility complex control of T cell responsivenessC E Mackewicz, B C Langton, C Y Leung, et al.
Molecular Immunology|May 1, 1986
Antigenic requirements for T-cell activation: reconstitution of a functional antigen from an inactive peptide portion of an antigen conjugated to protein carriersA M Wan, B C Langton, M L Andria, et al.
The Journal of Biological Chemistry|November 15, 1989
Identification of immunodominant regions of transforming growth factor alpha. Implications of structure and functionP D Hoeprich, B C Langton, J W Zhang, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 1, 1994
Development of resistance to cisplatin is associated with decreased expression of the gp185c-erbB-2 protein and alterations in growth properties and responses to therapy in an ovarian tumor cell lineB C Langton-Webster, J A Xuan, J R Brink, et al.
Advances in Experimental Medicine and Biology|January 1, 1985
Immune induction by a protein antigen and by a peptide segment of the proteinA M Wan, C D Estin, B C Langton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1988
Structural features of an antigen required for cellular interactions and for T cell activation in a MHC-restricted responseB C Langton, C E Mackewicz, A M Wan, et al.
Cancer Research|October 15, 1990
Increased erbB-2 gene copies and expression in multiple stages of breast cancerJ D Iglehart, M H Kraus, B C Langton, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Advances in Experimental Medicine and Biology|January 1, 1987
Structural considerations of T-cell cognizance of antigenE Benjamini, B C Langton, C E Mackewicz
Molecular Carcinogenesis|February 1, 1996
Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alphaS P Ethier, B C Langton, C A Dilts
Developments in Biological Standardization|January 1, 1986
Cell activation and immunogenicityE Benjamini, A M Wan, B C Langton, et al.
Cellular Immunology|March 1, 1991
Structural aspects of a protein epitope and their role in the major histocompatibility complex control of T cell responsivenessC E Mackewicz, B C Langton, C Y Leung, et al.
Molecular Immunology|May 1, 1986
Antigenic requirements for T-cell activation: reconstitution of a functional antigen from an inactive peptide portion of an antigen conjugated to protein carriersA M Wan, B C Langton, M L Andria, et al.
The Journal of Biological Chemistry|November 15, 1989
Identification of immunodominant regions of transforming growth factor alpha. Implications of structure and functionP D Hoeprich, B C Langton, J W Zhang, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 1, 1994
Development of resistance to cisplatin is associated with decreased expression of the gp185c-erbB-2 protein and alterations in growth properties and responses to therapy in an ovarian tumor cell lineB C Langton-Webster, J A Xuan, J R Brink, et al.
Advances in Experimental Medicine and Biology|January 1, 1985
Immune induction by a protein antigen and by a peptide segment of the proteinA M Wan, C D Estin, B C Langton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1988
Structural features of an antigen required for cellular interactions and for T cell activation in a MHC-restricted responseB C Langton, C E Mackewicz, A M Wan, et al.
Cancer Research|October 15, 1990
Increased erbB-2 gene copies and expression in multiple stages of breast cancerJ D Iglehart, M H Kraus, B C Langton, et al.
Pageof 3